Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferons.
Type I (alpha, beta) and type II (gamma) murine interferons are able to potentiate each other with respect to the inhibition of encephalomyocarditis (EMC) virus and of herpes simplex virus type 1 (HSV-1) multiplication in a murine cell line (DBT). Examination of two double-stranded RNA-dependent enzymes in DBT cells, the 2-5A synthetase and the 67,000 MW protein phosphokinase indicates that mixed interferon preparations act synergistically at least with respect to an increase in the activity of the former enzyme. The results obtained with gamma interferons of different origin and of different specific activity suggest that interferon itself, rather than the lymphokines present in the interferon preparations, is responsible for the synergistic effect.
D015088:2',5'-Oligoadenylate Synthetase / Q000096:biosynthesis; D000818:Animals; D002460:Cell Line; D004357:Drug Synergism; D004686:Encephalomyocarditis virus / Q000187:drug effects*; D004790:Enzyme Induction; D007370:Interferon Type I / Q000494:pharmacology*; D007371:Interferon-gamma / Q000494:pharmacology*; D051379:Mice; D011494:Protein Kinases / Q000096:biosynthesis; D018139:Simplexvirus / Q000187:drug effects*
D007370:Interferon Type I; D007371:Interferon-gamma; D011494:Protein Kinases; D015088:2',5'-Oligoadenylate Synthetase